[ad_1]
The World Health Organization (WHO) has stated that blood clotting has not yet been linked to the use of the Oxford-AstraZeneca corona vaccine. The UN agency says it believes there is no reason to stop using the vaccine.
Approximately 5 million people in Europe have already received the Oxford vaccine. Of these, 30 people showed signs of blood clots. However, the European Medicines Agency (EMA) says there is no evidence that the symptoms are due to the tick. And the benefits outweigh the risks. Even then, several countries, including Denmark and Norway, have canceled AstraZeneca’s immunization programs. Thailand has recently suspended its vaccination program at Oxford. The country’s prime minister canceled the immunization program, which was scheduled to start on Friday. However, no evidence of this suspicion was found.
At a press conference in Geneva on Friday, WHO spokeswoman Margaret Harris stated that “Oxford’s Covishield is an extraordinary vaccine like any other.
Harris believes that any concerns about tick protection need to be reviewed. “There are no restrictions on the use of the Oxford-Astrageneca vaccine,” he said. However, if there is any question about its safety, it should be investigated. But at the moment it is not correct to say that we will not use it. Source: BBC.
[ad_2]
